top of page


Your Clinical Regulatory Affairs Partners
Expert Advising for all your Clinical Regulatory needs, and eCDT Publishing


Avoid Costly FDA Delays. 
We Handle Your Regulatory + eCTD End-to-End.
From Pre-IND to Submission

Get Your FDA Submission Accepted Without Building a Large Internal Regulatory Team

ClinReg Partners believes in partnerships, not transactions. With this approach, ClinReg Partners works tirelessly to ensure that all clients receive the best support and advice on their clinical regulatory needs.

consultation

VALUED CLIENTS

Our team of experts helps bring new, promising products to the market and provides lifecycle regulatory support, ensuring compliance for your product portfolio. Our philosophy is an End-to-End approach, from Discovery to post-market maintenance activities.

​

Regulatory strategy for biotech startups approaching FDA milestones

We help pre-IND to end of Phase 2

avoid delays, reduce rework, and get aligned with FDA expectations before submission.

We identify regulatory risks, fix submission gaps, and prepare you for FDA interactions that determine your timeline.

​

whom we work with:

  • Biotech startups (Seed to Series B)

  • Preparing for IND, pre-IND, or End-of-Phase meetings

  • No in-house regulatory leadership or need for senior oversight

​

bottom of page